2 high quality ASX 50 shares named as buys

These ASX 50 shares could be top options for investors…

| More on:
Three excited business people cheer around a laptop in the office

Image source: Getty Images

The ASX 50 index is home to 50 of the largest listed companies on the Australian share market.

While there are a number of quality options on offer in the index, two that could be in the buy zone are listed below.

Here’s what you need to know about these ASX 50 shares:

CSL Limited (ASX: CSL)

The first ASX 50 share to look at is CSL. It is one of the world’s leading biotherapeutics companies.

It has been a very positive performer over the last decade. This has been driven by successful acquisitions, its high level of investment in R&D activities, a growing plasma collection network, and its leading therapies and vaccines.

In respect to the latter, CSL’s portfolio includes lucrative and life-saving products such as Privigen, Hizentra, Idelvion, and Afstyla. But it certainly isn’t resting on its laurels. This year the company will spend approximately US$1 billion again on R&D. This is to ensure it has a pipeline of lucrative products to drive future growth.

While the pandemic has hit plasma collections and could lead to elevated costs in the near term, this headwind is only expected to be temporary.

One broker that remains positive on the company is Morgans. It currently has an add rating and $324.40 price target.

SEEK Limited (ASX: SEK)

Another ASX 50 share to look at is SEEK. It is the leading job listings company in the ANZ region and has a number of growing businesses around the globe.

During FY 2021, the company returned to form and reported a 58% jump in net profit after tax excluding significant items to $141 million.

This was underpinned by record ad volumes in the second half of the year amid easing COVID-19 restrictions. This ultimately led to SEEK reporting an average of 40 million monthly site visits during the year, which represents 10% growth on pre-COVID-19 levels.

According to a note out of Macquarie, its analysts are confident this positive form will continue. Particularly given how unemployment levels are tipped to fall materially following the pandemic, which should support job ad volumes.

Macquarie has an outperform rating and $37.00 price target on the company’s shares.

Should you invest $1,000 in SEEK right now?

Before you consider SEEK, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and SEEK wasn't one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Motley Fool contributor James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has recommended SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares